Graeme F. Woodworth, MD, FACS is the Howard M. Eisenberg Distinguished Professor and the Chair of the Department of Neurosurgery at the University of Maryland School of Medicine (UMSOM), with secondary appointments in the Departments of Diagnostic Radiology and Nuclear Medicine, Bioengineering, and Neurobiology. He co-directs the Center for Metabolic Imaging and Therapeutics (CMIT) at UMSOM and the Neuroscience Network at University of Maryland Medical System, that he co-founded. He also serves as the director of the Brain Tumor Program at the University of Maryland Greenebaum Comprehensive Cancer Center.

Dr. Woodworth completed his bachelor’s degree from Tufts University, followed by medical school and neurosurgical residency at Johns Hopkins University. He completed the Johns Hopkins-NCI neuro-oncology and cancer nanomedicine postdoctoral fellowship, followed by a cranial neuro-endoscopy fellowship at Weill Cornell Neurosurgery. After serving as assistant chief of service for Johns Hopkins neurosurgery, he became faculty at UMSOM. Here, he provides leadership and surgical care within a multidisciplinary team of neurosurgeons, radiologists, neurologists, medical oncologists, radiation oncologists, and pathologists, treating brain cancer patients. He also directs the University of Maryland Faculty Practice Enterprises. His multiple clinical and administrative roles enable the cross-disciplinary group of engineers, cancer biologists, and clinician-scientists within the Translational Therapeutics Research Group (TTRG), which he codirects, to address key challenges in advancing brain tumor therapies.

Dr. Woodworth’s research focuses on improving clinical outcomes of brain tumor patients, through the development of novel diagnostic and therapeutic approaches, including transcranial focused ultrasound (FUS), laser interstitial thermal therapy, advanced nanoparticles, and patient-derived and genetically engineered human brain models for enhanced predictive therapeutic testing. His team has first-in-human clinical trials in the United States of FUS-mediated blood-brain-barrier-opening for brain tumors. For this work, he has received the Andrew J. Lockhart Memorial Prize and the Ferenc Jolenz Memorial Prize from the Focused Ultrasound Foundation.